Paratek Pharmaceuticals Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$133M
Industry:Pharma
Founded:1996
Lead Investor(s):BTIG, LLC
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Paratek Pharmaceuticals's estimated annual revenue is currently $17.1M per year.
  • Paratek Pharmaceuticals received $50.0M in venture funding in January 2018.
  • Paratek Pharmaceuticals's estimated revenue per employee is $92,027
  • Paratek Pharmaceuticals's total funding is $133M.

Employee Data

  • Paratek Pharmaceuticals has 186 Employees.
  • Paratek Pharmaceuticals grew their employee count by 9% last year.
  • Paratek Pharmaceuticals currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ironwood Pharma...
N/A445N/AN/A
Infinity Pharma...
N/A411N/AN/A
Kala Pharmaceut...
$10.7M1521%N/A
Karyopharm Ther...
$30.3M38550%N/A
Carna Bioscienc...
$4.6M27N/AN/A
PRECISIONadviso...
N/A5736%N/A
Boston Pharmace...
$14.3M8648%N/A
Vita Data Scien...
$8.4M5150%N/A
Veristat
$38M25815%N/A
Radius Health
N/A453N/AN/A
Missing a competitor? Contribute!?
Submit

Paratek Pharmaceuticals (NASDAQ: PRTK) is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments. We focus on drugs that target infectious disease and other difficult to treat conditions. Our lead product candidate, omadacycline, is the first in a new class of tetracyclines known as aminomethycyclines, with broad spectrum activity against Gram-positive, Gram-negative and atypical bacteria. Omadacycline is being developed as a once daily, oral and intravenous, empiric monotherapy for community acquired bacterial infections, particularly when antibiotic resistance is of concern. The Food and Drug Administration (FDA) granted omadacycline a Qualified Infectious Disease Product (QIDP) designation and completed two special protocol assessments for its Phase 3 clinical trial program.

keywords:Biotechnology,Healthcare,Mobile,Pharmaceuticals

186

Number of Employees

$17.1M

Revenue (est)

1

Current Jobs

9%

Employee Growth %

$133M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
Jeanne JewSenior VP, Business DevelopmentEmail Available
Susan PerkinsVice President, Intellectual PropertyEmail Available
Vaughn JenningsRegional Business ManagerEmail Available
John McPartlandDirector, Supply ChainEmail Available
Alexis ShawSenior Director, Compliance Email Available
Christopher BostromSenior Director of FinanceEmail Available
Ben StrainExecutive Director, Investor Relations And Corporate CommunicationsEmail Available
Sue DearClinical Development And Medical Affairs Operations ManagerEmail Available
Ron JacksonVice President, National SalesEmail Available
Mike BowmanRegional Business Manager

Paratek Pharmaceuticals News

09/07/2019 - Paratek Pharmaceuticals to Present at the 21st Annual HC ...

BOSTON, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company ...

09/08/2019 - Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Buckles ...

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) stock has been on a recent steady downtrend, causing some concern for shareholders.

09/03/2019 - Paratek Announces Inducement Grants under NASDAQ ...

BOSTON, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical ...

Paratek Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2002-04-11$30.2MDArticle
2004-10-01$13.7MUndisclosedBayerArticle
2007-10-26$22.0MHArticle
2008-04-17$40.0MUndisclosedAisling Capital, D.E. Shaw GroupArticle
2014-07-21$93.0MUndisclosedArticle
2015-04-29$69.0MUndisclosedLeerink PartnersArticle
2018-01-19$50.0MUndisclosedBTIG, LLCArticle

Paratek Pharmaceuticals Executive Hires

DateNameTitleReference
2002-08-13Donna SupkoDir Regulatory AffairsArticle
2003-02-13Joseph IanelliVP LicensingArticle
2003-10-30Sean M. JohnstonVP Manufacturing OpsArticle
2005-03-04John P DunphyVP/CFOArticle
2012-05-23Dennis MolnarCEOArticle
2014-07-02Michael F. BighamChairman/CEOArticle
2017-01-05Evan LohPresident and Chief Operating OfficerArticle

Paratek Pharmaceuticals New Location/Offices

DateLocationReference
2017-03-27King of Prussia, PAArticle

Paratek Pharmaceuticals Acquisitions

DateCompany NameAmountNotesReference
2014-07-03Transcept Pharmaceuticals, IncArticle

Paratek Pharmaceuticals Hiring Plans

DateNumber of EmployeesLocationReference
2008-07-1150Article